{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:47:06Z","timestamp":1784609226997,"version":"3.55.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Peripheral T-cell lymphoma (PTCL) is an aggressive and heterogeneous lymphoma subtype with high chemoresistance and poor prognosis. Common peripheral blood disease biomarkers with therapeutic potential are lacking. In this study, we analyzed the serum metabolic profiles of 557 patients with newly diagnosed PTCL, including 278 extranodal natural killer\/T-cell lymphoma (NKTCL), 117 patients with nodal T-follicular helper cell lymphoma (nTFHL), 92 with PTCL, not otherwise specified (PTCL-NOS), 36 with anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphoma (ALCL), and 34 with ALK-negative ALCL. We identified high free fatty acid (FFA) as an adverse prognostic biomarker across PTCL subtypes. Integrative analysis of transcriptomic and single-cell RNA-sequencing data sets further revealed that serum FFA linked to JAK-STAT signaling activation and a suppressive tumor microenvironment, characterized by increased infiltration of monocytic myeloid-derived suppressor cells (MDSCs) in NKTCL and M2 macrophages in nTFHL and PTCL-NOS, respectively. The selective JAK1 inhibitor golidocitinib showed pronounced antitumor efficacy in coculture systems under palmitic acid\u2013induced high-FFA conditions and in syngeneic and xenograft murine lymphoma models fed with high-fat diet through the JAK-STAT- interleukin-6 (IL-6)\/IL-10 axis-mediated inhibition of MDSCs in NKTCL and M2 macrophages in nTFHL and PTCL-NOS, respectively. In alignment with our experimental findings, relapsed or refractory patients with PTCL, who had high serum FFA levels, exhibited superior responses to golidocitinib treatment than those with low serum FFA levels. Collectively, high serum FFA is related to tumor progression and indicates golidocitinib sensitivity, providing novel insights into reprogramming lipid metabolism to dually target the tumor and microenvironment in PTCL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017682","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:50:58Z","timestamp":1769032258000},"page":"2125-2141","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Serum free fatty acid promotes tumor progression and predicts golidocitinib sensitivity in peripheral T-cell lymphoma"],"prefix":"10.1182","volume":"10","author":[{"given":"Yao","family":"Qin","sequence":"first","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-Hui","family":"Xia","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Hui","family":"Huang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Cheng","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Gao","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ci","family":"Cai","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ran","family":"Qiu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Hu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Shi","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Xu","family":"Yang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[{"name":"2Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiong","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-1616","authenticated-orcid":false,"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"3P\u00f4le de Recherches Sino-Fran\u00e7ais en Science du Vivant et G\u00e9nomique, Laboratory of Molecular Pathology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"7","key":"2026041408015317300_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"2026041408015317300_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ajh.27165","article-title":"Aggressive T-cell lymphomas: 2024: updates on diagnosis, risk stratification, and management","volume":"99","author":"Ong","year":"2024","journal-title":"Am J Hematol"},{"issue":"1","key":"2026041408015317300_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12943-023-01904-w","article-title":"Therapeutic challenges in peripheral T-cell lymphoma","volume":"23","author":"Luan","year":"2024","journal-title":"Mol Cancer"},{"issue":"6487","key":"2026041408015317300_bib4","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"1","key":"2026041408015317300_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"issue":"11","key":"2026041408015317300_bib6","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis","volume":"34","author":"Martin-Perez","year":"2022","journal-title":"Cell Metab"},{"issue":"10","key":"2026041408015317300_bib7","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1158\/0008-5472.CAN-18-2849","article-title":"Free fatty acids rewire cancer metabolism in obesity-associated breast cancer via estrogen receptor and mTOR signaling","volume":"79","author":"Madak-Erdogan","year":"2019","journal-title":"Cancer Res"},{"key":"2026041408015317300_bib8","doi-asserted-by":"crossref","first-page":"600350","DOI":"10.3389\/fcell.2020.600350","article-title":"Obesity-related fatty acid and cholesterol metabolism in cancer-associated host cells","volume":"8","author":"Ye","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2026041408015317300_bib9","first-page":"100426","article-title":"Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer\/T-cell lymphoma: a randomized phase III study","volume":"4","author":"Zhong","year":"2023","journal-title":"Innovation"},{"issue":"12","key":"2026041408015317300_bib10","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1535-7163.MCT-05-0146","article-title":"Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures","volume":"4","author":"Mahadevan","year":"2005","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"2026041408015317300_bib11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/pmic.200300374","article-title":"Proteomic analysis of a lymphoma-derived cell line (DG75) following treatment with a demethylating drug: modification of membrane-associated proteins","volume":"3","author":"Poirier","year":"2003","journal-title":"PROTEOMICS"},{"issue":"1","key":"2026041408015317300_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-024-01782-8","article-title":"Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma","volume":"9","author":"Xiong","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2026041408015317300_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/biom12040580","article-title":"Effects of glucose metabolism, lipid metabolism, and glutamine metabolism on tumor microenvironment and clinical implications","volume":"12","author":"Zhu","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"2026041408015317300_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7150\/thno.103376","article-title":"Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer","volume":"15","author":"Jiang","year":"2025","journal-title":"Theranostics"},{"key":"2026041408015317300_bib15","doi-asserted-by":"crossref","first-page":"104254","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell Immunol"},{"key":"2026041408015317300_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep"},{"issue":"10","key":"2026041408015317300_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41419-021-04217-2","article-title":"Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells","volume":"12","author":"Peng","year":"2021","journal-title":"Cell Death Dis"},{"key":"2026041408015317300_bib18","doi-asserted-by":"crossref","first-page":"590794","DOI":"10.3389\/fimmu.2020.590794","article-title":"Obesity-associated myeloid-derived suppressor cells promote apoptosis of tumor-infiltrating CD8 T cells and immunotherapy resistance in breast cancer","volume":"11","author":"Gibson","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"2026041408015317300_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","article-title":"Metabolic regulation of macrophage polarization in cancer","volume":"5","author":"Mehla","year":"2019","journal-title":"Trends Cancer"},{"issue":"1","key":"2026041408015317300_bib20","doi-asserted-by":"crossref","first-page":"2212532","DOI":"10.1080\/2162402X.2023.2212532","article-title":"T-cell dysfunction in natural killer\/T-cell lymphoma","volume":"12","author":"Feng","year":"2023","journal-title":"Oncoimmunology"},{"issue":"3","key":"2026041408015317300_bib21","doi-asserted-by":"crossref","first-page":"110695","DOI":"10.1016\/j.celrep.2022.110695","article-title":"Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma","volume":"39","author":"Cortes","year":"2022","journal-title":"Cell Rep"},{"issue":"10","key":"2026041408015317300_bib22","doi-asserted-by":"crossref","first-page":"e2306092","DOI":"10.1002\/advs.202306092","article-title":"Targeting the cGAS-STING pathway inhibits peripheral T-cell lymphoma progression and enhances the chemotherapeutic efficacy","volume":"11","author":"Lu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"2026041408015317300_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/gutjnl-2024-333530","article-title":"Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer\/T-cell lymphoma by dampening the JAK-STAT pathway","volume":"74","author":"Shi","year":"2025","journal-title":"Gut"},{"key":"2026041408015317300_bib24","doi-asserted-by":"crossref","first-page":"104420","DOI":"10.1016\/j.ebiom.2022.104420","article-title":"Histone deacetylases inhibitor chidamide synergizes with humanized PD1 antibody to enhance T-cell chemokine expression and augment Ifn-\u03b3 response in NK-T cell lymphoma","volume":"87","author":"Wen","year":"2023","journal-title":"eBioMedicine"},{"issue":"1","key":"2026041408015317300_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12916-025-04230-8","article-title":"Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer\/T-cell lymphoma by enhancing antitumor immunity","volume":"23","author":"Shi","year":"2025","journal-title":"BMC Med"},{"issue":"4","key":"2026041408015317300_bib26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ijc.2910420421","article-title":"Expression of the Epstein-Barr virus encoded EBNA-I gene in stably transfected human and murine cell lines","volume":"42","author":"Patel","year":"1988","journal-title":"Int J Cancer"},{"issue":"10","key":"2026041408015317300_bib27","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.164.10.5094","article-title":"The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin","volume":"164","author":"Gays","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"2026041408015317300_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.celrep.2018.06.054","article-title":"Antigen-presenting cell-intrinsic PD-1 neutralizes PD-L1 in cis to attenuate PD-1 signaling in T cells","volume":"24","author":"Zhao","year":"2018","journal-title":"Cell Rep"},{"key":"2026041408015317300_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jconrel.2022.07.010","article-title":"Antibody-mediated depletion of programmed death 1-positive (PD-1+) cells","volume":"349","author":"Zhai","year":"2022","journal-title":"J Control Release"},{"issue":"1","key":"2026041408015317300_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0029665121003761","article-title":"Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism","volume":"81","author":"Nagarajan","year":"2022","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"2026041408015317300_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41467-022-35704-5","article-title":"BMI-adjusted adipose tissue volumes exhibit depot-specific and divergent associations with cardiometabolic diseases","volume":"14","author":"Agrawal","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"2026041408015317300_bib32","doi-asserted-by":"crossref","first-page":"2100199","DOI":"10.1183\/13993003.00199-2021","article-title":"A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity","volume":"58","author":"Zhu","year":"2021","journal-title":"Eur Respir J"},{"issue":"21","key":"2026041408015317300_bib33","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.scib.2023.09.029","article-title":"GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis","volume":"68","author":"Xiong","year":"2023","journal-title":"Sci Bull"},{"issue":"1","key":"2026041408015317300_bib34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026041408015317300_bib35","doi-asserted-by":"crossref","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"2026041408015317300_bib36","doi-asserted-by":"crossref","first-page":"2004507","DOI":"10.1002\/advs.202004507","article-title":"Hypermethylation of hepatic mitochondrial ND6 provokes systemic insulin resistance","volume":"8","author":"Cao","year":"2021","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"2026041408015317300_bib37","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"issue":"1","key":"2026041408015317300_bib38","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1002\/iub.2942","article-title":"APOC1 inhibit NKTCL doxorubicin sensitivity by promoting mitophagy","volume":"77","author":"Xiao","year":"2025","journal-title":"IUBMB Life"},{"issue":"1","key":"2026041408015317300_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13046-024-02952-w","article-title":"Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment","volume":"43","author":"Krug","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"2026041408015317300_bib40","doi-asserted-by":"crossref","first-page":"106534","DOI":"10.1016\/j.leukres.2021.106534","article-title":"Low serum cholesterol levels predict inferior prognosis and improve prognostic index scoring for peripheral T-cell lymphoma, unspecified","volume":"103","author":"Tang","year":"2021","journal-title":"Leuk Res"},{"issue":"5","key":"2026041408015317300_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-immunol-110416-120628","article-title":"Disorders of the JAK\/STAT pathway in T cell lymphoma pathogenesis: implications for immunotherapy","volume":"35","author":"Waldmann","year":"2017","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2026041408015317300_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-018-0678-1","article-title":"Advances in multiple omics of natural-killer\/T cell lymphoma","volume":"11","author":"Xiong","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2026041408015317300_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40164-021-00200-x","article-title":"Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas","volume":"10","author":"Ye","year":"2021","journal-title":"Exp Hematol Oncol"},{"issue":"12","key":"2026041408015317300_bib44","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1158\/0008-5472.CAN-20-3121","article-title":"Epstein\u2013Barr Virus induces adipocyte dedifferentiation to modulate the tumor microenvironment","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res"},{"issue":"36","key":"2026041408015317300_bib45","doi-asserted-by":"crossref","first-page":"e2303913","DOI":"10.1002\/advs.202303913","article-title":"Single-cell analysis reveals malignant cells reshape the cellular landscape and foster an immunosuppressive microenvironment of extranodal NK\/T-cell lymphoma","volume":"10","author":"Li","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"2026041408015317300_bib46","doi-asserted-by":"crossref","first-page":"101416","DOI":"10.1016\/j.xcrm.2024.101416","article-title":"Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes","volume":"5","author":"Huang","year":"2024","journal-title":"Cell Rep Med"},{"issue":"1","key":"2026041408015317300_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41375-021-01321-2","article-title":"High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL)","volume":"36","author":"Pritchett","year":"2022","journal-title":"Leukemia"},{"issue":"19","key":"2026041408015317300_bib48","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","article-title":"GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2026041408015317300_bib49","doi-asserted-by":"crossref","first-page":"102029","DOI":"10.1016\/j.xcrm.2025.102029","article-title":"A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities","volume":"6","author":"Fiore","year":"2025","journal-title":"Cell Rep Med"},{"issue":"5","key":"2026041408015317300_bib50","first-page":"1352","article-title":"Nicotinamide N -methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma","volume":"78","author":"Li","year":"2023","journal-title":"Hepatology"},{"key":"2026041408015317300_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cellimm.2018.07.003","article-title":"IL-10 induces an immune repressor pathway in sepsis by promoting S100A9 nuclear localization and MDSC development","volume":"332","author":"Bah","year":"2018","journal-title":"Cell Immunol"},{"issue":"2","key":"2026041408015317300_bib52","doi-asserted-by":"crossref","first-page":"e23828","DOI":"10.4161\/jkst.23828","article-title":"Targeting the tumor microenvironment","volume":"2","author":"Bournazou","year":"2013","journal-title":"JAK-STAT"},{"key":"2026041408015317300_bib53","doi-asserted-by":"crossref","first-page":"731798","DOI":"10.3389\/fphar.2021.731798","article-title":"PD-1\/PD-L1 checkpoint inhibitors in tumor immunotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"4","key":"2026041408015317300_bib54","doi-asserted-by":"crossref","first-page":"e164793","DOI":"10.1172\/jci.insight.164793","article-title":"Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment","volume":"8","author":"Gao","year":"2023","journal-title":"JCI Insight"},{"issue":"6702","key":"2026041408015317300_bib55","doi-asserted-by":"crossref","first-page":"eade8520","DOI":"10.1126\/science.ade8520","article-title":"JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma","volume":"384","author":"Zak","year":"2024","journal-title":"Science"},{"issue":"1","key":"2026041408015317300_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1470-2045(23)00589-2","article-title":"Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study","volume":"25","author":"Song","year":"2024","journal-title":"Lancet Oncol"},{"issue":"11","key":"2026041408015317300_bib57","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.annonc.2023.08.013","article-title":"Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas","volume":"34","author":"Song","year":"2023","journal-title":"Ann Oncol"},{"issue":"7746","key":"2026041408015317300_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-019-0945-5","article-title":"Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death","volume":"567","author":"Garcia-Bermudez","year":"2019","journal-title":"Nature"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2125\/2510684\/blooda_adv-2025-017682-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2125\/2510684\/blooda_adv-2025-017682-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:02:03Z","timestamp":1776168123000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/7\/2125\/566165\/Serum-free-fatty-acid-promotes-tumor-progression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017682","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,14]]},"published":{"date-parts":[[2026,3,25]]}}}